Fast Answer
For a supplement brand, “liver detox ingredients” should not be treated as a promise that a product will cleanse, cure, repair, or reverse liver disease. A safer and more useful formulation route is to compare ingredients by their role in normal liver biology, bile-acid or nutrient context, documentation quality, format fit, sensory profile, dosage feasibility, and claim boundary.
Nutrition BioTech helps teams evaluate liver-support and detox-positioned ingredients as formulation routes, not miracle claims: which material fits capsules, stick packs or combination formulas; which documentation is ready for quality review; and where marketing language needs to stay inside a defensible support boundary.
Why “Detox” Copy Needs a Better Buyer Standard
“Detox” is attention-grabbing, but it is also one of the easiest categories to overclaim. Consumers may read it as a promise that a supplement removes toxins or fixes liver problems. Regulatory, quality and brand teams need a cleaner standard.
A stronger buyer question is: What liver-support role can this ingredient reasonably occupy, and can the supplier document the material well enough for a real product launch?
- Is this a nutrient-support route, a bile-acid route, an antioxidant/botanical route, or a metabolic-support adjacent route?
- Is the ingredient suitable for the finished format?
- What claims should be avoided?
- What proof package should be requested before sampling?
- What internal links and consumer education are needed so the product page does not overpromise?
Ingredient Routes to Compare
| Route | Why buyers consider it | Format and proof questions |
|---|---|---|
| TUDCA / bile-acid route | Used in scientific and clinical literature in bile-acid and liver-related contexts. | Requires careful claim boundary. Ask for assay, specification, impurity profile, COA, stability and capsule/stick-pack fit. Do not turn clinical literature into broad supplement cure language. |
| Choline route | NIH ODS describes choline as an essential nutrient involved in phospholipid synthesis and liver biology. | Stronger as a nutrient-support and routine-support route. Check dose feasibility, taste, hygroscopicity, label positioning and upper-intake caution. |
| Milk thistle / silymarin route | Familiar consumer liver-support botanical. | Evidence and extract quality vary. Ask for standardization, solvent/residue documentation, heavy metals, allergen statements and claim-safe wording. |
| DHM route | Often used in alcohol-aftercare and liver-adjacent consumer formulas. | Needs very careful language. Avoid hangover cure or alcohol-protection promises. Check solubility, taste, dosage, capsule fill and sensory masking for gummies/sticks. |
| Antioxidant / combination route | Brands may combine liver-support ingredients with metabolic, hydration or recovery positioning. | Combination formulas increase claim and interaction complexity. Require formula-level review instead of judging each ingredient alone. |
What to Ask Before Sampling
- What is the exact ingredient identity, assay method and specification?
- Is the ingredient route appropriate for capsules, powders, stick packs, gummies or RTD formats?
- What sensory issue should the brand expect: bitterness, sulfur note, acidity, color shift or aftertaste?
- What stability data or method data is available for the intended format?
- What claims are supportable, and which claims should be avoided?
- Can the supplier provide COA, specification, allergen statement, GMO statement, heavy metals/micro testing and traceability documents?
- Does the supplier understand the difference between scientific literature, finished-product claims and consumer-facing copy?
Claim-Safe Positioning Language
Use language like “supports normal liver-health formulation positioning,” “for liver-support and detox-positioned supplement development,” “designed for claim-aware formulation review,” “documentation-ready ingredient route,” and “evaluate format fit before launch.”
Avoid language that directly promises detoxification, liver repair, fatty-liver reversal, alcohol protection, disease treatment, or a clinically proven cure.
Nutrition BioTech Formulation Support
Nutrition BioTech supplies advanced nutraceutical ingredients for brands that need more than a raw-material name. For liver-support and detox-positioned formulas, our work is to help buyers compare ingredient routes, finished-format fit, documentation readiness and claim boundary before a product reaches the line.
For buyer review, request the relevant COA, specification, allergen/GMO statements, traceability information, format notes and sample discussion for your intended route.
CTA: Request a liver-support ingredient review or sample package.
Related Buyer Guides
- Recovery & liver-support ingredients
- TUDCA vs milk thistle / silymarin
- TUDCA vs DHM (Dihydromyricetin) — compound class, assay basis, origin documentation and format fit for two very different raw materials
- How to verify a supplier COA
- Quality certifications
Identity and Standardisation: What to Specify on a COA for Liver-Support Ingredients
Liver-support quotes are hard to compare because the same ingredient name can hide different molecules, salt forms, or mixtures. An identifier-first specification removes that ambiguity. Every registry identifier below was verified against the PubChem registry before publication.
| Ingredient | CAS No. | Molecular formula | MW (g/mol) | Specification note |
|---|---|---|---|---|
| Tauroursodeoxycholic acid (TUDCA, free acid) | 14605-22-2 | C₂₆H₄₅NO₆S | 499.7 | Taurine-conjugated bile acid; state assay basis (free acid vs salt) |
| Sodium tauroursodeoxycholate | 35807-85-3 | C₂₆H₄₄NNaO₆S | 521.7 | ≈95.8% free-acid equivalents by molecular weight |
| Ursodeoxycholic acid (UDCA) | 128-13-2 | C₂₄H₄₀O₄ | 392.6 | Unconjugated parent bile acid — a different molecule from TUDCA |
| Dihydromyricetin (DHM, ampelopsin) | 27200-12-0 | C₁₅H₁₂O₈ | 320.25 | (2R,3R) flavanonol; request validated HPLC identity |
| Silybin (silibinin) | 22888-70-6 | C₂₅H₂₂O₁₀ | 482.4 | Reference marker for silymarin assays |
| Silymarin (complex) | 65666-07-1 | Mixture | — | Mixture CAS; assay must state method and expression basis |
Salt basis changes the number. Sodium tauroursodeoxycholate (CAS 35807-85-3, MW 521.7) delivers approximately 95.8% TUDCA free-acid equivalents by molecular weight (499.7 ÷ 521.7 = 0.958). A lot assayed at 98% on the sodium-salt basis therefore corresponds to roughly 0.939 g free-acid TUDCA equivalents per gram. Two “TUDCA 98%” quotes are not comparable until both state whether the basis is the free acid (CAS 14605-22-2) or the sodium salt — our guide on how to compare ingredient quotes covers this class of discrepancy.
Conjugation is an identity boundary, not a detail. TUDCA (CAS 14605-22-2) is the taurine conjugate of ursodeoxycholic acid (CAS 128-13-2). They carry different CAS numbers, different molecular formulas, and different molecular weights, so a certificate of analysis issued for one cannot substantiate the other. Identity testing on each lot should confirm the conjugated molecule itself.
A mixture CAS does not fix composition. CAS 65666-07-1 designates the silymarin flavonolignan complex as a whole, not any fixed ratio of its constituents. A “% silymarin” figure is only meaningful when the COA states the analytical method and the expression basis (typically expressed as silybin, CAS 22888-70-6), because different validated methods can return materially different values on the same lot. Ask for the marker profile, not just the total.
Formula and weight cannot confirm stereochemistry. CAS 27200-12-0 designates (2R,3R)-dihydromyricetin. Because stereoisomers share the same molecular formula (C₁₅H₁₂O₈) and weight (320.25), identity should be confirmed by a validated chromatographic method against a qualified reference standard, as described in our guide on how to verify a supplier COA.
FAQ
What are liver detox ingredients?
In supplement formulation, liver detox ingredients are usually nutrients, botanicals, bile-acid-related ingredients or combination routes used in liver-support or detox-positioned products. They should be evaluated by claim boundary, documentation and format fit, not by unsupported cleansing promises.
Can a supplement detox the liver?
Public supplement copy should avoid promising that a product detoxifies, repairs or treats the liver. A safer route is to describe claim-aware liver-support formulation, normal nutrition support, ingredient documentation and format-specific product development.
What documentation should a buyer request for liver-support ingredients?
A buyer should request COA, specification, assay method, heavy metals and microbiology results, allergen and GMO statements, traceability information, stability or method data when available, and a clear claim boundary for the intended market.
Which format is best for liver-support ingredients?
There is no single best format. Capsules may fit bitter or higher-dose materials better; stick packs and gummies require stronger sensory and stability review; RTD applications need solubility, pH and stability checks before launch.
How do I convert a sodium TUDCA assay to free-acid TUDCA equivalents?
Multiply the salt-basis assay by 0.958, the ratio of the free-acid molecular weight to the sodium-salt molecular weight (499.7 ÷ 521.7). A lot assayed at 98% as sodium tauroursodeoxycholate corresponds to roughly 93.9% free-acid TUDCA equivalents. Ask the supplier to state the assay basis and the CAS number on the COA so quotes can be compared on the same basis.
Is a TUDCA COA interchangeable with a UDCA COA?
No. TUDCA (CAS 14605-22-2) and UDCA (CAS 128-13-2) are different molecules with different molecular formulas and weights. A certificate of analysis for one cannot substantiate the other, and each lot should carry identity testing for the specific conjugate being supplied.
What should a silymarin specification state besides the percentage?
The analytical method and the expression basis. CAS 65666-07-1 designates the silymarin complex as a mixture, so a total percentage alone does not define composition. A complete specification states the method, the reference basis (typically expressed as silybin, CAS 22888-70-6), and the marker profile of the lot.